NCT06641388View on ClinicalTrials.gov

A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

June 17, 2025

Conditions
Healthy Subjects (HS)
Interventions
DRUG

Ebronucimab

Ebronucimab subcutaneous injection

DRUG

Ebronucimab

Ebronucimab subcutaneous injection

Trial Locations (1)

Unknown

The Third Xiangya Hospital of Central South University, Changsha

Sponsors

Lead Sponsor

Akeso
All Listed Sponsors
lead

Akeso

INDUSTRY

NCT06641388 - A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects | Biotech Hunter | Biotech Hunter